Cleavage resistant analogue of GLP-1 that stimulates insulin secretion. Contains N-terminal Cyanine-3 fluorescent dye.
Catalogue number crb1130605 Molecular Weight 4866.4 Sequence (one letter code)
Sequence (three letter code)
Purity >95% Storage -20°C References
Kolterman, O. G., Kim, D. D., Shen L., Ruggles J. A., Nielsen L. L., Fineman M. S., Baron A. D. (2005) Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus. Am J Health Syst Pharm 62: 173–181. PMID: 15700891
Liao, S., Liang, Y., Zhang, Z., Li, J., Wang, J., Wang, X., Dou, G., Zhang, Z. and Liu, K. (2015). In Vitro Metabolic Stability of Exendin-4: Pharmacokinetics and Identification of Cleavage Products. PLOS ONE, 10(2), e0116805.
Luciani, P., Deledda, C., Benvenuti, S., Squecco, R., Cellai, I., Fibbi, B., Marone, I., Giuliani, C., Modi, G., Francini, F., Vannelli, G. and Peri, A. (2013). Exendin-4 Induces Cell Adhesion and Differentiation and Counteracts the Invasive Potential of Human Neuroblastoma Cells. PLoS ONE, 8(8), e71716. PMID: 23990978
Manufactured in: United Kingdom
Exendin-4 is part of a group of peptide hormones, the exendins, which are members of the glucagon superfamily of peptides and are secreted from the Gila monster lizard (Heloderma suspectum) venom gland. Exendins stimulate insulin secretion in response to rising blood glucose levels, and modulate gastric emptying to slow the entry of ingested sugars into the bloodstream. Exendin-4 increases insulin sensitivity and improves glucose tolerance in humans and animals with diabetes. Exendin-4 is currently used for the treatment of type 2 diabetes mellitus in its synthetic form Exenatide.
Exendin-4 shares 53% sequence homology, and certain activities, with glucagon-like-peptide-1 (GLP-1). GLP-1 is produced by enteroendocrine L-cells upon nutrient ingestion and its main role is related to insulin secretion. Unlike GLP-1, exendin-4 is resistant to cleavage by plasma dipeptidyl peptidase IV (DPP-IV), resulting in a longer half-life and duration of action than GLP-1, as well as greater potency in vivo. Exendin-4 binds and activates the glucagon-like peptide-1 receptor (GLP-1R). In addition to its role in insulin sensitivity, exendin-4 also has a role in pancreas development and has anti-cancer properties.
This peptide contains an N-terminal Cyanine-3 dye. Cyanine-3 is an orange fluorescent dye with emission maximum around 564 nm
You may also like…
Teduglutide (GLP2 2G)
Exendin 4 (4–39)